What is Dbaza?
Dbaza Inc operates at the intersection of healthcare and technology, specializing in the development of tailored digital health interventions designed to improve patient adherence. The company utilizes a proprietary cloud-based MLT platform that empowers clients to define, develop, and deploy highly personalized engagement strategies. By addressing the specific personal barriers that impede patient adherence, Dbaza provides critical value to a broad spectrum of stakeholders, including Fortune 500 pharmaceutical companies, medical technology firms, insurers, and clinical research organizations. The platform leverages sophisticated data-driven insights to foster customer loyalty and promote healthier lifestyle outcomes, effectively bridging the gap between clinical intent and patient behavior.
How much funding has Dbaza raised?
Dbaza has raised a total of $100K across 1 funding round:
Debt
$100K
Debt (2021): $100K with participation from PPP
Key Investors in Dbaza
PPP
Public-Private Partnership
What's next for Dbaza?
Following this major strategic investment, Dbaza is poised to enter a phase of aggressive expansion and product refinement. The company is expected to leverage this capital to enhance its MLT platform capabilities, potentially integrating more advanced predictive analytics to further personalize patient engagement. As the healthcare industry continues to prioritize value-based care and patient-centric models, Dbaza's focus on measurable adherence outcomes positions it as a vital partner for large-scale healthcare systems. Future growth will likely center on deepening its penetration within the pharmaceutical sector and expanding its footprint in clinical research, where data-driven patient activation is increasingly critical to trial success and long-term therapeutic efficacy.
See full Dbaza company page
